Dr Anne Moore with microneedle patches on her hand Image Tomás Tyner
Researchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses of vaccine in pre-clinical testing.
The lead researcher, Dr Anne Moore, heads to Silicon Valley next week to meet venture capitalists and leading technology companies with a view to commercialising the research.
The microneedle-based patch also overcomes one of the main problems with this type of vaccine which relates to overcoming pre-existing immunity to the vaccine. The scientists combined two vaccine technologies to determine if immunity could be further enhanced and the research suggests that using a microneedle patch would overcome the need to make and use multiple different vaccine types to induce protective immunity to some of the world’s biggest killers. This could have significant consequences on the costs and logistics of vaccination.
The work was carried out by researchers in the School of Pharmacy, Dept. of Pharmacology and the Tyndall National Institute, UCC, led by Dr Anne Moore in collaboration with colleagues at the Jenner Institute, University of Oxford and was published byNature Publication Group in Scientific Reports and funded by Enterprise Ireland and Science Foundation Ireland. Dr Moore’s visit to Silicon Valley is being hosted by the Irish Technology Leadership Group (ITLG) as part of an SFI initiative for researchers to help them develop their entrepreneurial skills in the Get Started Venture Technology programme.
The skin patch has arrays of tiny silicon ‘microneedles’ that painlessly create temporary pores in the very outermost barrier layer of the skin, permitting the vaccine to flow into the skin, which is rich in cells of the immune system. The experimental vaccine was based on a live adenovirus. This virus is similar to those that can cause a common cold, but is engineered to be safer and to deliver a protein from the malaria-causing parasite, to the immune system.
The Latest on: Malaria vaccine
via Google News
The Latest on: Malaria vaccine
- Malaria vaccine could help boost controlon November 29, 2021 at 4:16 am
It’s been several decades in the making, but a malaria vaccine has finally won approval for general use. The World Health Organisation’s recent recommendation for widespread use of the RTS, S/AS01 ...
- Did Dr. Fauci say malaria was nearly non-existent in the US due to vaccines?on November 28, 2021 at 10:49 am
Director of the National Institute of Allergy and Infectious Diseases (NIAID) and the Chief Medical Advisor to the President, Dr. Anthony Fauci cruised the Sunday shows today and spent some time with ...
- Okonjo-Iweala Lobbies For Investment In Malaria Vaccineon November 26, 2021 at 10:28 pm
The director general of the World Trade Organisation, Dr. Ngozi Okonjo-Iweala, has asked the world to invest in the newly recommended malaria vaccine and thousands of children in countries whose ...
- WHO Approves First Malaria Vaccineon November 26, 2021 at 4:23 am
The first malaria vaccine has been endorsed by the WHO, according to a report published by The New York Times. The vaccine is given in three doses between 5 and 17 months, with a fourth dose about 18 ...
- WHO recommends malaria vaccine for childrenon November 24, 2021 at 6:57 pm
In a historic moment, WHO backs RTS,S, the first antiparasite vaccine to be recommended for widespread use in malaria control. Vijay Shankar Balakrishnan reports.
- The world finally has a malaria vaccine. Now it must invest in iton November 23, 2021 at 11:00 pm
As an economist I know it makes financial as well as ethical sense to get this world-first vaccine to the millions who need it ...
- Examining the effects of malaria parasites on global healthon November 22, 2021 at 6:21 am
News-Medical speaks to Professor Kevin Baird about his lifelong research into malaria and how another malaria parasite, P. Vivax, is taking a toll on global health.
- The Brilliant but Widely Loathed Scientist Behind the AstraZeneca Vaccineon November 20, 2021 at 5:37 pm
Eddie Keogh/ReutersIt was 2019 and Adrian Hill was still waiting for his success.The 61-year-old British molecular geneticist had spent nearly three decades working with a colleague, Sarah Gilbert, on ...
- Explained: Why It Took 54 Years For A Malaria Vaccineon November 18, 2021 at 10:23 pm
Scientific challenges, lower research funding and less attention from rich countries means companies are less interested in developing vaccines for diseases such as TB and malaria, as compared ...
- More malaria vaccines in the pipelineon November 18, 2021 at 3:37 am
Researchers are calling for more partnerships and funding for malaria programmes, while 2.3-million children in three African countries have already received a jab ...
via Bing News
